Flavonoids Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Global Flavonoids Market Report is Segmented by Type (Anthocyanin, Flavones, Isoflavones, Flavanol, and More), Source (Citrus Fruits, Berries, and More), Form (Powder, Liquid, and Others) Application (Food and Beverages, Nutraceutical, Pharmaceutical, and More); and by Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Flavonoid Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Flavonoid Market with other markets in Food & Beverage Industry

Flavonoid Market Analysis by Mordor Intelligence

The Flavonoids market is valued at USD 1.42 billion in 2025 and is expected to reach USD 1.82 billion by 2030, growing at a CAGR of 5.11%. The market growth is driven by regulations supporting natural colorants, improved extraction technologies, and increased consumer demand for functional nutraceuticals and cosmetics. The Food and Drug Administration's amendment to color additive regulations now permits the expanded use of butterfly pea flower extract in various food products, including ready-to-eat cereals, crackers, snack mixes, hard pretzels, plain potato chips, corn chips, tortilla chips, and multigrain chips at levels aligned with good manufacturing practice (GMP). This regulatory change, effective June 26, 2025, responds to a color additive petition (CAP) from Sensient Colors, LLC, and indicates an industry shift toward botanical pigments.[1]Source: Federal Register, "Listing of Color Additives Exempt From Certification; Butterfly Pea Flower Extract", federalregister.gov Moreover, Ohio State University's development of shelf-stable anthocyanin blues enhances functionality in acidic environments. North America dominates the market due to established FDA guidelines, while the Asia-Pacific region shows growth driven by increasing disposable income and favorable nutraceutical regulations. Supply constraints in citrus and berries affect raw material availability; however, fermentation-based production methods offer potential solutions to stabilize price fluctuations.

Key Report Takeaways

  • By product type, anthocyanins led with 29.53% of the Flavonoids market share in 2024, while flavonols recorded the highest 6.37% CAGR through 2030.
  • By source, berries captured 27.45% share of the Flavonoids market size in 2024; herbs and spices are projected to expand at 6.64% CAGR between 2025-2030.
  • By form, powder commanded 63.83% share of the Flavonoids market size in 2024; the innovative “other” segment advances at 6.74% CAGR through 2030.
  • By application, nutraceuticals held 35.70% of the Flavonoids market share in 2024 and are advancing at 5.81% CAGR through 2030.
  • By geography, North America dominated with 32.45% revenue share in 2024; Asia-Pacific exhibits the swiftest 6.42% CAGR through 2030.

Segment Analysis

By Type: Anthocyanins Retain Lead While Flavonols Accelerate

Anthocyanins dominated the Flavonoids market with a 29.53% share in 2024, driven by their applications as natural colorants and antioxidants. Recent regulatory approvals for butterfly pea and increased demand for natural blue colors in beverage reformulations support this segment's growth. Flavonols, particularly quercetin, demonstrate a 6.37% CAGR, supported by expanding applications in cardiovascular and metabolic health. Recent developments in water-soluble 3-hydroxyflavonol technology enhance bioavailability, increasing clinical applications. Flavan-3-ols maintain stable growth due to FDA cardiovascular qualified health claims for cocoa powders, while flavones and isoflavones serve specific hormonal health applications. During the forecast period, increased therapeutic validation and pharmaceutical trials position flavonols to reduce the market share gap.

The market for flavonols continues to expand through ongoing research and development, while anthocyanins maintain their market position through color innovation. Manufacturers gain competitive advantages through improved stability technologies, securing premium contracts with major beverage and beauty companies. Growing clinical evidence for flavonol efficacy is expected to increase healthcare provider acceptance and expand over-the-counter availability, facilitating broader market penetration in mainstream health channels.

Market Analysis of Flavonoid Market: Chart for TYPE
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Source: Berries Dominate but Herbs and Spices Gain Ground

Berries contributed 27.45% of the Flavonoids market size in 2024, supported by established supply chains and widespread use of blueberry and blackcurrant extracts. However, climate-related yield variations create price volatility that affects processor margins. The herbs and spices segment grows at 6.64% CAGR, supported by the continuous cultivation of Scutellaria and rosemary, which provide concentrated active compounds at lower doses. Citrus maintains its market position through efficient hesperidin production, though disease and drought concerns lead to geographic diversification of sources. Soybean isoflavones serve the menopause support segment, while tea and cocoa maintain stable demand due to traditional consumption patterns.

Manufacturers distribute sourcing across hemispheres to minimize weather-related disruptions and maintain market stability. Fermentation facilities test baicalin production using stainless-steel bioreactors, reducing dependence on crop cycles and minimizing pesticide exposure. This approach ensures consistent quality and meets environmental, social, and governance (ESG) requirements, positioning herb-derived and fermentation-derived flavonoids as risk management tools. As regulatory requirements for product disclosure increase, supply chain traceability becomes crucial in supplier selection, benefiting sources with comprehensive audit systems.

By Form: Powder Remains Pre-Eminent While Novel Systems Emerge

Powder formats maintained a 63.83% market share in 2024, primarily due to their shelf stability, ease of blending, and compatibility with existing dry-mix infrastructure. Liquid variants are essential for beverage and cosmetic emulsions requiring rapid dispersion but face challenges with oxidation and microbial contamination, which reduce shelf life. The "others" category, experiencing a 6.74% CAGR, includes nanogels, beadlets, and co-extruded cylinders that improve bioavailability and enable pH-triggered release. Aqueous two-phase extraction technology produces high-purity concentrates suitable for injectable pharmaceuticals.

End-users prioritize cost per effective dose over raw material costs, making high-loading beadlets economically viable despite higher unit prices. Advanced moisture-barrier film packaging helps maintain product potency and reduces waste. The industry's shift toward clean labels has increased the adoption of solvent-free granulation methods. While powder formats continue to dominate the Flavonoids market, the industry is gradually moving toward specialized delivery systems that influence product development strategies.

Market Share,
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Application: Nutraceuticals Drive Multi-Sector Expansion

Nutraceuticals hold 35.70% of the Flavonoids market share in 2024 and maintain a 5.81% CAGR, driven by physician-supported claims for joint health, liver function, and immune system support. Food and beverage manufacturers are reformulating products with plant-based colors, supported by the 2025 GRAS regulatory reforms emphasizing transparency. The pharmaceutical industry is conducting Phase 1 and Phase 2 clinical trials of chrysin and quercetin for metabolic disorders, suggesting potential prescription drug development. The cosmetics industry incorporates anthocyanin complexes for UV protection, with increasing adoption of combined topical and oral treatment approaches.

The animal feed industry is evaluating Scutellaria flavonoids as natural growth promotants, in response to regulations limiting antimicrobial use in livestock. Multi-purpose applications, such as packaging films that function as pH indicators, demonstrate how single extracts can benefit multiple industrial segments. This diversification protects the Flavonoids market from demand fluctuations in individual sectors while encouraging innovation that extends intellectual property across multiple categories.

Geography Analysis

North America accounted for 32.45% of 2024 revenue, supported by FDA health-claim clarity and established supplement distribution channels. The region faces challenges from citrus greening disease and extreme weather conditions, driving companies to source ingredients from Latin America or through fermentation processes. IFF's USD 70 million investment in February 2025 to expand its Cedar Rapids, Iowa, facility by 47,000 square feet demonstrates a commitment to domestic production. The expansion, scheduled for completion in 2026, will increase Taura by IFF fruit ingredients production to serve the healthy snacks market. While retailers value U.S.-grown ingredients, buyers accept imported alternatives during domestic supply shortages and price increases.

Asia-Pacific shows the highest growth rate at 6.42% CAGR, driven by expanding middle-class consumption, acceptance of traditional medicine, and emerging manufacturing centers. China's incorporation of validated flavonoids in its functional-food catalogue and India's Ayurvedic standards create efficient approval processes, reducing time-to-market. The expansion of e-commerce beyond urban areas increases market penetration and sales volume.

Europe maintains consistent growth, supported by strict additive regulations and environmentally conscious consumers. EFSA's reassessment of existing colorants creates opportunities for flavonoid alternatives that avoid extensive toxicological reviews. Ongoing drought conditions reduce EU citrus production, limiting regional hesperidin availability and increasing interest in Blackcurrant and Elderberry alternatives. The cosmetics industry in France and Italy benefits from comprehensive regulations covering 309 approved colorants, facilitating faster development of skincare products containing flavonoids.

Market Analysis of Flavonoid Market: Forecasted Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The global flavonoid market is moderately fragmented. The market features prominent players like Merck KGaA, Foodchem International, Indena S.p.A, Cayman Chemical Company, and Layn Natural Ingredients, leading the industry through various strategic initiatives. Companies are heavily investing in research and development to discover novel flavonoid compounds and enhance existing product portfolios, particularly focusing on improving bioavailability and efficacy. 

HealthTech Bioactives and Abolis Biotechnologies have developed solvent-free fermentation technology that reduces solvent disposal costs and increases product purity to pharmaceutical standards. The increase in patent filings for microfluidic and high-pressure homogenization techniques indicates growing competition for intellectual property rights and associated royalty revenues. New market participants are utilizing contract manufacturing partnerships to accelerate commercialization without significant capital expenditure.

Givaudan's expansion in the Asia-Pacific region demonstrates strategic positioning to minimize supply chain risks and gain geographical advantages. Companies now achieve competitive advantages through regulatory compliance, supply chain optimization, and comprehensive efficacy documentation rather than production capacity increases. This market environment favors organizations with operational flexibility and specialized industry knowledge.

Flavonoid Industry Leaders

  1. Cayman Chemical Company

  2. Merck KGaA

  3. Indena S.p.A

  4. Layn Natural Ingredients

  5. Bordas Chinchurreta SA

  6. *Disclaimer: Major Players sorted in no particular order
Flavonoid Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • February 2025: In February 2025, Naturex (a Givaudan brand) introduced a new range of stable anthocyanin-based natural colorants in its VegeBrite ColorBright portfolio. These colorants improve heat and pH stability in beverage and confectionery applications.
  • October 2024: Givaudan initiated construction of a CHF 50 million manufacturing facility in Cikarang, Indonesia. The 24,000-square-meter facility will manufacture savory, sweet, and snack powders, along with infant nutrition products. Operations are scheduled to commence in the first half of 2026.
  • May 2024: HealthTech Bioactives partnered with Abolis Biotechnologies to develop solvent-free, fermentation-based production methods for polyphenols, initially focusing on two high-value molecules with plans to expand to eight additional compounds. This collaboration aims to enhance manufacturing capacities and reduce costs compared to traditional extraction methods.

Table of Contents for Flavonoid Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand for Anti-Inflammatory Joint Health Supplements
    • 4.2.2 Antiviral and Antimicrobial Applivational in Natural Remeddies
    • 4.2.3 Use as Natural Colorants in Food and Beverage
    • 4.2.4 Increasing Demand for Anti-Bacterial Properties in Skincare Products
    • 4.2.5 Expanding Consumer Preference for Natural and Functional Food Ingredients
    • 4.2.6 Technological Innovations Drive Efficient Extraction and Purification Methods
  • 4.3 Market Restraints
    • 4.3.1 Limited Shelf Life
    • 4.3.2 Regulatory Restriction on Health Claims
    • 4.3.3 Potential Allergic Reaction and Drug Interactions
    • 4.3.4 Dependency on Seasonal and Regional Crop Supply
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Porter’s Five Forces
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Type
    • 5.1.1 Anthocyanin
    • 5.1.2 Flavones
    • 5.1.3 Flavan-3-ols
    • 5.1.4 Flavonol
    • 5.1.5 Anthoxanthin
    • 5.1.6 Isoflavones
    • 5.1.7 Other Product Types
  • 5.2 By Source
    • 5.2.1 Citrus Fruits
    • 5.2.2 Berries
    • 5.2.3 Soybeans
    • 5.2.4 Tea
    • 5.2.5 Cocoa
    • 5.2.6 Herbs and Spices
    • 5.2.7 Others
  • 5.3 By Form
    • 5.3.1 Powder
    • 5.3.2 Liquid
    • 5.3.3 Others
  • 5.4 By Application
    • 5.4.1 Food and Beverages
    • 5.4.2 Nutraceutical
    • 5.4.3 Pharmaceutical
    • 5.4.4 Cosmetic and Personal Care
    • 5.4.5 Animal Feed
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.1.4 Rest of North America
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 Italy
    • 5.5.2.4 France
    • 5.5.2.5 Spain
    • 5.5.2.6 Netherlands
    • 5.5.2.7 Poland
    • 5.5.2.8 Belgium
    • 5.5.2.9 Sweden
    • 5.5.2.10 Rest of Europe
    • 5.5.3 Asia
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 Indonesia
    • 5.5.3.6 South Korea
    • 5.5.3.7 Thailand
    • 5.5.3.8 Singapore
    • 5.5.3.9 Rest of Asia Pacific
    • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Colombia
    • 5.5.4.4 Chile
    • 5.5.4.5 Peru
    • 5.5.4.6 Rest of South America
    • 5.5.5 Middle East and Africa
    • 5.5.5.1 South Africa
    • 5.5.5.2 Saudi Arabia
    • 5.5.5.3 United Arab Emirates
    • 5.5.5.4 Nigeria
    • 5.5.5.5 Egypt
    • 5.5.5.6 Morocco
    • 5.5.5.7 Turkey
    • 5.5.5.8 Rest of Middle East and Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.4.1 Indena S.p.A.
    • 6.4.2 Layn Natural Ingredients
    • 6.4.3 Merck KGaA (Sigma-Aldrich)
    • 6.4.4 Cayman Chemical
    • 6.4.5 Extrasynthese
    • 6.4.6 Foodchem International
    • 6.4.7 DSM-Firmenich
    • 6.4.8 Archer Daniels Midland (ADM)
    • 6.4.9 Cargill
    • 6.4.10 Givaudan Active Beauty
    • 6.4.11 Naturex (Givaudan)
    • 6.4.12 Sabinsa Corporation
    • 6.4.13 Synthite Industries
    • 6.4.14 Kemin Industries
    • 6.4.15 Evolva AG
    • 6.4.16 Blue California
    • 6.4.17 BioSpectrum
    • 6.4.18 Bioriginal Food & Science
    • 6.4.19 Ingredients By Nature
    • 6.4.20 Venkatesh Natural Extracts
    • 6.4.21 Indofine Chemical

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Flavonoid Market Report Scope

Flavonoids can be defined as a species of polyphenolic lower-level metabolites originating from plants that are consumed as dietary food. The global flavonoid market is segmented by type, application, and geography. By type, the market is segmented into flavanone, anthocyanin, flavan-3-ols, flavonols, anthoxanthin, isoflavones, and other types. Further, the market has been segmented by application into nutraceuticals, pharmaceuticals, cosmetics, food processing, and animal feed. Also, the study provides an analysis of the flavonoids market in emerging and established markets across the world, including North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The market sizing has been done in value terms in USD for all the abovementioned segments.

By Type Anthocyanin
Flavones
Flavan-3-ols
Flavonol
Anthoxanthin
Isoflavones
Other Product Types
By Source Citrus Fruits
Berries
Soybeans
Tea
Cocoa
Herbs and Spices
Others
By Form Powder
Liquid
Others
By Application Food and Beverages
Nutraceutical
Pharmaceutical
Cosmetic and Personal Care
Animal Feed
By Geography North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
Italy
France
Spain
Netherlands
Poland
Belgium
Sweden
Rest of Europe
Asia China
India
Japan
Australia
Indonesia
South Korea
Thailand
Singapore
Rest of Asia Pacific
South America Brazil
Argentina
Colombia
Chile
Peru
Rest of South America
Middle East and Africa South Africa
Saudi Arabia
United Arab Emirates
Nigeria
Egypt
Morocco
Turkey
Rest of Middle East and Africa
By Type
Anthocyanin
Flavones
Flavan-3-ols
Flavonol
Anthoxanthin
Isoflavones
Other Product Types
By Source
Citrus Fruits
Berries
Soybeans
Tea
Cocoa
Herbs and Spices
Others
By Form
Powder
Liquid
Others
By Application
Food and Beverages
Nutraceutical
Pharmaceutical
Cosmetic and Personal Care
Animal Feed
By Geography
North America United States
Canada
Mexico
Rest of North America
Europe Germany
United Kingdom
Italy
France
Spain
Netherlands
Poland
Belgium
Sweden
Rest of Europe
Asia China
India
Japan
Australia
Indonesia
South Korea
Thailand
Singapore
Rest of Asia Pacific
South America Brazil
Argentina
Colombia
Chile
Peru
Rest of South America
Middle East and Africa South Africa
Saudi Arabia
United Arab Emirates
Nigeria
Egypt
Morocco
Turkey
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current Flavonoids market size and how fast is it growing?

Flavonoids market is estimated at USD 1.42 billion in 2025 and is anticipated to reach USD 1.82 billion by 2030, registering a 5.11% CAGR.

Which product type leads the Flavonoids market?

Anthocyanins lead with 29.53% 2024 share, though flavonols post the fastest 6.37% CAGR.

Why is Asia-Pacific the fastest-growing region?

Supportive nutraceutical rules, rising disposable income, and local manufacturing investments such as Givaudan’s new Indonesian plant fuel a 6.42% CAGR.

Which application segment shows the strongest momentum?

Nutraceuticals dominate with 35.70% share and remain the fastest growing at 5.81% CAGR, supported by clinical validation and updated FDA labeling rules.

Page last updated on: July 3, 2025